Estás viendo estas citas basadas en búsquedas anteriores relacionadas con sectores como
Nombre | P / E | PEG | Rentabilidad por dividendo | Margen operativo | ROCE | Retorno sobre Activos |
---|---|---|---|---|---|---|
4basebio | -25.5 | 0.0 | 0.00% | - 2,179.10% | - 0.70% | - 0.44% |
Farmacia 4D | 0.0 | 0.0 | 0.00% | - 13,502.49% | - 2.92% | - 1.26% |
Abcam | 0.0 | 0.0 | 0.00% | 5.27% | 0.07% | 0.02% |
Abzená | 0.0 | 0.0 | 0.00% | - 68.06% | - 0.65% | - 0.26% |
Agronomía limitada | 3.7 | 0.0 | 0.00% | n / a | 0.13% | 0.13% |
Terapias de alergia | -0.4 | 0.0 | 0.00% | - 59.27% | - 1.30% | - 0.75% |
Alianza Farmacéutica | 7.9 | -0.2 | 5.22% | 6.31% | 0.16% | 0.00% |
Grupo de cuidado de animales | 20.7 | -1.5 | 2.21% | 5.93% | 0.26% | 0.01% |
Anpario | 16.9 | -1.2 | 4.12% | 8.14% | 0.11% | 0.06% |
Grupo Aptamer | -0.1 | 0.0 | 0.00% | - 465.58% | - 6.27% | - 2.85% |
Aqua Bounty Technologies Inc. (Registro S) | 0.0 | 0.0 | 0.00% | n / a | - 1.28% | - 1.08% |
Terapéutica Arecor | -4.3 | 0.0 | 0.00% | - 442.36% | - 0.72% | - 0.43% |
VPN (DI) de Argent Biopharma Limited | n / a | n / a | n / a | n / a | n / a | n / a |
AstraZeneca | 39.3 | 0.5 | 1.92% | 17.88% | 0.60% | 0.06% |
Grupo Avacta | -3.1 | 0.0 | 0.00% | - 326.25% | - 0.72% | - 0.42% |
Participaciones de referencia | -18.7 | 0.0 | 0.00% | - 3.14% | - 0.03% | - 0.05% |
Beximco Pharmaceuticals Ltd. RDA (Reg S) | 995.3 | 45.4 | 0.02% | 21.99% | 0.11% | 0.06% |
Productos farmacéuticos Biodexa | n / a | n / a | n / a | n / a | n / a | n / a |
Biofrontera AG (DI) | 0.0 | 0.0 | 0.00% | - 279.67% | - 1.02% | - 0.77% |
bioventix | 27.7 | 3.1 | 3.42% | 78.28% | 0.83% | 0.63% |
Terapéutica BiVictriX | -3.0 | 0.0 | 0.00% | n / a | - 0.73% | - 0.55% |
BTG | 0.0 | 0.0 | 0.00% | 14.00% | 0.23% | 0.07% |
Participaciones de descubrimiento C4X | -2.7 | 0.0 | 0.00% | - 784.44% | - 2.35% | - 1.26% |
n / a | n / a | n / a | n / a | n / a | n / a | |
Grupo Chill Brands | -1.3 | 0.0 | 0.00% | - 496.82% | - 0.90% | - 0.70% |
Participaciones de Cizzle Biotechnology | -5.5 | 0.0 | 0.00% | n / a | n / a | - 0.33% |
ciprotex | 0.0 | 0.0 | 0.00% | 12.68% | 0.15% | - 0.42% |
Dechra productos farmacéuticos | -157.2 | 0.0 | 0.32% | 0.83% | 0.01% | - 0.02% |
Deepverge Plc | 0.1 | 0.0 | 0.00% | - 36.34% | - 0.32% | - 0.09% |
Farmacia del destino | -2.8 | 0.0 | 0.00% | n / a | - 0.98% | - 0.57% |
Grupo diurno | 0.0 | 0.0 | 0.00% | - 404.68% | - 0.89% | - 0.62% |
e-Terapéutica | -6.0 | 0.0 | 0.00% | - 2,155.58% | - 0.31% | - 0.24% |
EastPharma Ltd RDA (Reg S) | 0.0 | 0.0 | 0.00% | 12.96% | 0.09% | 0.02% |
Grupo ECO de Sanidad Animal | 73.8 | 0.0 | 0.00% | 5.27% | 0.08% | 0.01% |
Investigación del Edén | n / a | n / a | n / a | n / a | n / a | n / a |
Ergonómico | 31.6 | 8.7 | 0.00% | 12.99% | 0.55% | 0.12% |
Faron Pharmaceuticals Oy (DI) | -3.4 | 0.0 | 0.00% | n / a | 9.10% | - 3.03% |
Futura Médica | -15.8 | 0.0 | 0.00% | - 224.57% | - 1.27% | - 0.55% |
Genflow Biociencias | -4.4 | 0.0 | 0.00% | n / a | - 0.56% | - 0.51% |
Género | 21.0 | 8.3 | 1.80% | 5.87% | 0.08% | 0.03% |
GSK | 10.8 | 1.0 | 2.51% | 22.24% | 0.67% | 0.08% |
gunsynd | -0.4 | 0.0 | 0.00% | 158.53% | - 0.80% | - 0.76% |
GW Pharmaceuticals | 0.0 | 0.0 | 0.00% | - 200.53% | - 0.24% | - 0.15% |
halcón | 19.2 | -3.2 | 1.81% | 17.66% | 0.70% | 0.03% |
Productos farmacéuticos Hemogenyx | -2.6 | 0.0 | 0.00% | n / a | - 1.23% | - 1.10% |
Productos farmacéuticos de Hikma | 10.9 | 0.5 | 2.97% | 12.77% | 0.16% | 0.04% |
Grupo de descubrimiento de horizonte | 0.0 | 0.0 | 0.00% | - 17.27% | - 0.21% | - 0.03% |
HUTCHMED (China) limitada | 31.8 | 0.0 | 0.00% | 2.19% | 0.03% | 0.08% |
hvivo | 0.0 | 0.0 | 0.00% | - 164.40% | - 1.23% | - 0.60% |
immufarma | -1.7 | 0.0 | 0.00% | n / a | - 1.48% | - 0.96% |
individuo | 1,838.2 | 0.0 | 0.00% | - 0.37% | - 0.07% | 0.00% |
Capital inspirado | 0.0 | 0.0 | 0.00% | - 0.82% | 0.00% | 0.00% |
Ixico | -3.3 | 0.0 | 0.00% | - 21.56% | - 0.25% | - 0.09% |
LungLife AI, Inc (DI) | -1.8 | 0.0 | 0.00% | - 12,243.48% | - 1.61% | - 0.57% |
Maxcyte Inc (DI / REG S) | n / a | n / a | n / a | - 116.98% | - 0.19% | - 0.14% |
Grupo Mereo Biopharma | 0.0 | 0.0 | 0.00% | n / a | - 1.28% | - 0.40% |
Motivo Bio | 0.0 | 0.0 | 0.00% | n / a | - 1.59% | - 1.23% |
Farmacia N4 | -1.5 | 0.0 | 0.00% | - 71,249.99% | n / a | - 1.00% |
Nuformix | -2.4 | 0.0 | 0.00% | n / a | n / a | - 0.19% |
VAN de Okyo Pharma Limited | 0.0 | 0.0 | 0.00% | n / a | n / a | - 1.21% |
VAN (CDI) de Ondine Biomedical Inc. | -0.9 | 0.0 | 0.00% | - 2,940.91% | - 1.53% | - 1.17% |
Salud OptiBiotix | 5.9 | -0.1 | 0.00% | - 544.64% | n / a | 0.22% |
Ovoca Bio (CDI) | -0.1 | 0.0 | 0.00% | n / a | - 1.74% | - 0.60% |
Oxford Biomédica | -1.6 | 0.0 | 0.00% | - 205.69% | - 1.11% | - 0.62% |
Participaciones de Oxford Cannabinoid Technologies | -0.6 | 0.0 | 0.00% | n / a | - 1.80% | - 1.32% |
Tecnologías Oxford Nanopore | -5.5 | 0.0 | 0.00% | - 99.38% | - 0.25% | - 0.20% |
Pfizer Inc. | n / a | n / a | n / a | 1.81% | n / a | n / a |
OJSC Pharmstandard RDA (Reg S) | n / a | n / a | n / a | n / a | n / a | n / a |
Participaciones de Plethora Solutions | 0.0 | 0.0 | 0.00% | - 419.63% | - 3.55% | - 2.76% |
Farmacia Poolbeg | -11.9 | 0.0 | 0.00% | n / a | - 0.31% | - 0.24% |
Ciencias del proteoma | -4.3 | 0.0 | 0.00% | - 32.24% | - 0.25% | - 0.21% |
Salud PureTech | -11.4 | 0.0 | 0.00% | - 4,390.36% | - 0.08% | - 0.10% |
Farmacéutica cuántica | 0.0 | 0.0 | 0.00% | - 11.10% | - 1.17% | - 0.25% |
Farmacia redx | -1.2 | 0.0 | 0.00% | - 804.85% | - 1.56% | - 1.29% |
Grupo ReNeuron | -0.4 | 0.0 | 0.00% | - 1,342.45% | - 1.34% | - 0.56% |
Participaciones de Sareum | -5.2 | 0.0 | 0.00% | n / a | - 3.53% | - 1.58% |
Participaciones de Scancell | -6.4 | 0.0 | 0.00% | - 226.14% | - 1.21% | - 0.39% |
Terapéutica de escudo | -0.1 | 0.0 | 0.00% | - 904.72% | 55.74% | - 1.83% |
Shire plc | 0.0 | 0.0 | 0.00% | 16.19% | 0.32% | 0.06% |
Terapéutica del silencio | 0.0 | 0.0 | 0.00% | - 654.20% | - 28.50% | - 0.38% |
Farmacia Sinclair | 0.0 | 0.0 | 0.00% | - 4.77% | 0.11% | 0.00% |
PielBioTerapéutica | -5.4 | 0.0 | 0.00% | - 2,271.26% | - 1.57% | - 1.09% |
skyepharma | 0.0 | 0.0 | 0.00% | 32.85% | 0.59% | 0.25% |
Fuente BioScience | 0.0 | 0.0 | 0.00% | 8.94% | 0.17% | 0.03% |
Cumbre Terapéutica | 0.0 | 0.0 | 0.00% | 6.21% | 0.08% | 0.13% |
sinairgen | -0.7 | 0.0 | 0.00% | n / a | - 1.00% | - 0.75% |
Taiwán | 0.0 | 0.0 | 0.00% | - 88.11% | n / a | - 0.22% |
Theracryf | n / a | n / a | n / a | n / a | n / a | n / a |
Ciencias de la vida de Tiziana | 0.0 | 0.0 | 0.00% | n / a | - 0.47% | - 0.39% |
Valirx | -1.1 | 0.0 | 0.00% | n / a | - 1.91% | - 0.60% |
Grupo Vectura | 0.0 | 0.0 | 0.00% | 69.67% | 0.47% | 0.18% |
Verici DX | -1.4 | 0.0 | 0.00% | n / a | - 1.18% | - 0.80% |
Vernalis plc | 0.0 | 0.0 | 0.00% | - 127.03% | - 0.43% | - 0.23% |
Farmacia Verona | 0.0 | 0.0 | 0.00% | n / a | - 1.30% | - 0.71% |
Verseon Corporation (DI / REG S) | 0.0 | 0.0 | 0.00% | n / a | - 0.42% | - 0.38% |
Corporación Verseon (Reg S Cat 3) | 0.0 | 0.0 | 0.00% | n / a | - 0.42% | - 0.38% |
Salud de Yourgene | -1.7 | 0.0 | 0.00% | - 6.76% | - 0.08% | - 0.03% |